FDA Inspection 1284308 — Abryl Laboratories Private Limited
The FDA completed an inspection of Abryl Laboratories Private Limited on September 26, 2025 in Dera Bassi SAS Nagar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 26, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dera Bassi SAS Nagar (India)